806 related articles for article (PubMed ID: 14691214)
21. Preferential induction of CYP1A1 and CYP1B1 in CCSP-positive cells.
Chang H; Chang LW; Cheng YH; Tsai WT; Tsai MX; Lin P
Toxicol Sci; 2006 Jan; 89(1):205-13. PubMed ID: 16237193
[TBL] [Abstract][Full Text] [Related]
22. Comparative 32P-postlabeling analysis of benzo[a]pyrene--DNA adducts formed in vitro upon activation of benzo[a]pyrene by human, rabbit and rodent liver microsomes.
Roggeband R; Wolterbeek AP; Rutten AA; Baan RA
Carcinogenesis; 1993 Sep; 14(9):1945-50. PubMed ID: 8403223
[TBL] [Abstract][Full Text] [Related]
23. Effect of dietary restriction on benzo[a]pyrene (BaP) metabolic activation and pulmonary BaP-DNA adduct formation in mouse.
Chen W; Zhou Y; Nichols J; Chung KT; Hart RW; Chou MW
Drug Chem Toxicol; 1996; 19(1-2):21-39. PubMed ID: 8804551
[TBL] [Abstract][Full Text] [Related]
24. Validation of precision-cut liver slices in dynamic organ culture as an in vitro model for studying CYP1A1 and CYP1A2 induction.
Drahushuk AT; McGarrigle BP; Tai HL; Kitareewan S; Goldstein JA; Olson JR
Toxicol Appl Pharmacol; 1996 Oct; 140(2):393-403. PubMed ID: 8887457
[TBL] [Abstract][Full Text] [Related]
25. Resveratrol, a natural aryl hydrocarbon receptor antagonist, protects lung from DNA damage and apoptosis caused by benzo[a]pyrene.
Revel A; Raanani H; Younglai E; Xu J; Rogers I; Han R; Savouret JF; Casper RF
J Appl Toxicol; 2003; 23(4):255-61. PubMed ID: 12884409
[TBL] [Abstract][Full Text] [Related]
26. Effects of intravenous benzo[a]pyrene dose administration on levels of exposure biomarkers, DNA adducts, and gene expression in rats.
Moreau M; Ouellet N; Ayotte P; Bouchard M
J Toxicol Environ Health A; 2015; 78(3):166-84. PubMed ID: 25506633
[TBL] [Abstract][Full Text] [Related]
27. Polycyclic aromatic hydrocarbon-inducible DNA adducts: evidence by 32P-postlabeling and use of knockout mice for Ah receptor-independent mechanisms of metabolic activation in vivo.
Kondraganti SR; Fernandez-Salguero P; Gonzalez FJ; Ramos KS; Jiang W; Moorthy B
Int J Cancer; 2003 Jan; 103(1):5-11. PubMed ID: 12455047
[TBL] [Abstract][Full Text] [Related]
28. Benzo[a]pyrene and tumor necrosis factor-α coordinately increase genotoxic damage and the production of proinflammatory mediators in alveolar epithelial type II cells.
Umannová L; Machala M; Topinka J; Schmuczerová J; Krčmář P; Neča J; Šujanová K; Kozubík A; Vondráček J
Toxicol Lett; 2011 Oct; 206(2):121-9. PubMed ID: 21745554
[TBL] [Abstract][Full Text] [Related]
29. Genetic polymorphisms in catalase and CYP1B1 determine DNA adduct formation by benzo(a)pyrene ex vivo.
Schults MA; Chiu RK; Nagle PW; Wilms LC; Kleinjans JC; van Schooten FJ; Godschalk RW
Mutagenesis; 2013 Mar; 28(2):181-5. PubMed ID: 23325794
[TBL] [Abstract][Full Text] [Related]
30. Qualitative and quantitative differences in the induction and inhibition of hepatic benzo[a]pyrene metabolism in the rat and hamster.
Wroblewski VJ; Gessner T; Olson JR
Biochem Pharmacol; 1988 Apr; 37(8):1509-17. PubMed ID: 3358781
[TBL] [Abstract][Full Text] [Related]
31. Modulation of adult rat benzo(a)pyrene (BaP) metabolism and DNA adduct formation by neonatal diethylstilbestrol (DES) exposure.
Ramesh A; Inyang F; Knuckles ME
Exp Toxicol Pathol; 2004 Dec; 56(3):129-38. PubMed ID: 15625781
[TBL] [Abstract][Full Text] [Related]
32. Effect of arsenic on benzo[a]pyrene DNA adduct levels in mouse skin and lung.
Evans CD; LaDow K; Schumann BL; Savage RE; Caruso J; Vonderheide A; Succop P; Talaska G
Carcinogenesis; 2004 Apr; 25(4):493-7. PubMed ID: 14578163
[TBL] [Abstract][Full Text] [Related]
33. DNA adducts formation and induction of apoptosis in rat liver epithelial 'stem-like' cells exposed to carcinogenic polycyclic aromatic hydrocarbons.
Topinka J; Marvanová S; Vondrácek J; Sevastyanova O; Nováková Z; Krcmár P; Pencíková K; Machala M
Mutat Res; 2008 Feb; 638(1-2):122-32. PubMed ID: 17961608
[TBL] [Abstract][Full Text] [Related]
34. Benzo(a)pyrene-induced alterations in growth-related gene expression and signaling in precision-cut adult rat liver and kidney slices.
Parrish AR; Fisher R; Bral CM; Burghardt RC; Gandolfi AJ; Brendel K; Ramos KS
Toxicol Appl Pharmacol; 1998 Oct; 152(2):302-8. PubMed ID: 9852999
[TBL] [Abstract][Full Text] [Related]
35. Benzo[a]pyrene-7,8-quinone-3'-mononucleotide adduct standards for 32P postlabeling analyses: detection of benzo[a]pyrene-7,8-quinone-calf thymus DNA adducts.
Balu N; Padgett WT; Nelson GB; Lambert GR; Ross JA; Nesnow S
Anal Biochem; 2006 Aug; 355(2):213-23. PubMed ID: 16797471
[TBL] [Abstract][Full Text] [Related]
36. DNA adduct formation in mammalian cell cultures by polycyclic aromatic hydrocarbons (PAH) and nitro-PAH in coke oven emission extract.
Topinka J; Schwarz LR; Kiefer F; Wiebel FJ; Gajdos O; Vidová P; Dobiás L; Fried M; Srám RJ; Wolff T
Mutat Res; 1998 Nov; 419(1-3):91-105. PubMed ID: 9804906
[TBL] [Abstract][Full Text] [Related]
37. Up-regulation of CYP1A/B in rat lung and liver, and human liver precision-cut slices by a series of polycyclic aromatic hydrocarbons; association with the Ah locus and importance of molecular size.
Pushparajah DS; Umachandran M; Nazir T; Plant KE; Plant N; Lewis DF; Ioannides C
Toxicol In Vitro; 2008 Feb; 22(1):128-45. PubMed ID: 17920237
[TBL] [Abstract][Full Text] [Related]
38. Dose responses for DNA adduct formation in tissues of rats and mice exposed by inhalation to low concentrations of 1,3-[2,3-[(14)C]-butadiene.
Booth ED; Kilgour JD; Robinson SA; Watson WP
Chem Biol Interact; 2004 Mar; 147(2):195-211. PubMed ID: 15013821
[TBL] [Abstract][Full Text] [Related]
39. Induction of Cyp1a1 and Cyp1b1 and formation of DNA adducts in C57BL/6, Balb/c, and F1 mice following in utero exposure to 3-methylcholanthrene.
Xu M; Nelson GB; Moore JE; McCoy TP; Dai J; Manderville RA; Ross JA; Miller MS
Toxicol Appl Pharmacol; 2005 Nov; 209(1):28-38. PubMed ID: 15885734
[TBL] [Abstract][Full Text] [Related]
40. Role of cytochrome P4501B1 in benzo[a]pyrene bioactivation to DNA-binding metabolites in mouse vascular smooth muscle cells: evidence from 32P-postlabeling for formation of 3-hydroxybenzo[a]pyrene and benzo[a]pyrene-3,6-quinone as major proximate genotoxic intermediates.
Moorthy B; Miller KP; Jiang W; Williams ES; Kondraganti SR; Ramos KS
J Pharmacol Exp Ther; 2003 Apr; 305(1):394-401. PubMed ID: 12649394
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
